Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Recombinant T Cell Receptor antibody

Reactivity: Human FACS, IP, IF, BR Host: Rabbit Chimeric BMA031 unconjugated Recombinant Antibody
Catalog No. ABIN7543145
  • Target
    T Cell Receptor
    Antibody Type
    Recombinant Antibody
    Reactivity
    • 7
    • 2
    Human
    Host
    • 4
    • 3
    • 2
    Rabbit
    Clonality
    • 7
    • 2
    Chimeric
    Conjugate
    • 8
    • 1
    Un-conjugated
    Application
    • 9
    • 7
    • 5
    • 4
    • 3
    • 1
    • 1
    • 1
    Flow Cytometry (FACS), Immunoprecipitation (IP), Immunofluorescence (IF), Blocking Reagent (BR)
    Purpose
    Anti-TCR [BMA031], Rabbit IgG, kappa
    Specificity
    This antibody reacts with surface receptors on all alpha-beta TCR bearing cells, but does not react with receptors on gamma-delta T cells. TCR-αβ is expressed by the majority of mature CD3+ T cells.
    Characteristics

    Original Species of Ab: Mouse

    Original Format of Ab: IgG2b

    Purification
    Protein A affinity purified
    Immunogen
    The original antibody was generated by immunizing mice with human perihperal blood T-lymphocytes.
    Clone
    BMA031
    Isotype
    IgG kappa
  • Application Notes
    This antibody is recomended for detection of viable human αβ+ TCR lymphocyte. It is highly effective in modulating immune reactions and is capable of activating human T lymphocytes in vito (PMID: 3092794). Double immunofluorescence staining was used to ascertain that this antibody does not cross react with γδ+ TCR cells. FACS analysis confirmed that BMA031 did not react with γδ+ TCR cells. BMA031 successfully precipitates TCR αβ/CDR complex (PMID: 1704361). BMA031 in conjugation with triple drug induction treatment in kidney-transplanted patients showed no side effects and reduction in graft rejections (PMID: 2978369). A clinical phase II trial administered 50 mg of murine anti-human alpha/beta-TCR mAb (BMA 031) intravenously on the day of, as well as 2 and 4 days after, cadaveric donor renal transplantation in combination with a CsA/prednisone regimen. After a minimum of 30 months follow-up, the actual allograft survival rate was 87 % in the BMA-treated group compared with 68 % in the control cohort (PMID: 8009591).Humanized version of this antibody BMA 031-EUCIV3 is found to have 2.5 times less affinity than its murine parent, however the ability to cause antibody dependent cell-mediated cytolysis was significantly enhanced (PMID: 1836485).
    Comment

    This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2b format, for improved compatibility with existing reagents, assays and techniques.

    Restrictions
    For Research Use only
  • Concentration
    1 mg/mL
    Buffer
    PBS with 0.02 % Proclin 300.
    Preservative
    ProClin
    Precaution of Use
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Storage
    4 °C,-20 °C
    Storage Comment
    Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.
  • Target
    T Cell Receptor
    Alternative Name
    TCR
    Background
    Human α/β T Cell Receptor (TCR)
You are here:
Support